Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

Helen F. Graham Cancer Center
& Research Institute

Multidisciplinary Care: A Full Team of Experts In Your Corner

You will appreciate the convenience of receiving all of your services under one roof at the Helen F. Graham Cancer Center & Research Institute, but the advantages to our multidisciplinary approach go much deeper. Studies show that patients who receive their cancer screening, prevention, treatment and palliative-care services in a setting of multispecialty care tend to live longer and have a better quality of life. And because our model of care is based on multidisciplinary centers, every patient benefits from a team of experts who are focused on his or her individual care.

What is a multidisciplinary center, and how does it benefit me?

A cancer multidisciplinary center, or MDC, is an organizational unit of doctors from different specialties who collaborate to focus on caring for patients with a specific type of cancer.

When you visit the Helen F. Graham Cancer Center, you will meet with your nurse navigator and a team of doctors in one visit. Your team will be made up of doctors who specialize in your type of cancer and typically includes:

  • A surgeon who can order diagnostic tests, perform a biopsy to see if your tumor is malignant or operate to remove cancer if necessary.
  • A medical oncologist who can administer chemotherapy or immunotherapy that kills cancer cells.
  • A radiation oncologist who can pinpoint places where your cancer is growing and use precisely focused X-rays to reduce or destroy it.

Together, these cancer specialists, in consultation with your primary-care doctor, will work with you to create the most appropriate and effective plan of treatment for your cancer.

Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Newark, DE 19713 directions
302-623-4500